Proton Pump Inhibitors Use in Patients With Psoriasis

• Status: Unknown status
• Trial end date: 2016-12-01
• Target enrollment: 0
• Participant gender: All

Summary

Proton pump inhibitors act in blocking acid secretion and also have antioxidant and anti-inflammatory properties. For that mechanisms possibly PPIs may have an anti-inflammatory action with improvement in skin lesions in patients with psoriasis.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: EMS
• Treatments: Desonide; Esomeprazole; Proton Pump Inhibitors

Criteria

Inclusion Criteria:

• Diagnostic of Psoriasis

Exclusion Criteria:

• Pregnancy